Des His1, Glu8 Exendin-4 removes two charged residues, reshaping the N-terminal electrostatic landscape. The modified sequence enables evaluation of positions critical for receptor binding and activation. Researchers apply this analog to dissect exendin-4 domain contributions to secondary structure. Its engineered alterations support comparative structure-activity and signaling studies.
CAT No: E10004
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More